Foghorn Therapeutics Inc. (FHTX)
4.92
+0.05 (1.03%)
Upcoming Events
Latest Headlines
Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel Amid Early Pipeline Excitement
August 17, 2026 7:10 AM - StreetInsider
Foghorn Therapeutics Inc. (FHTX) Tops Q2 EPS by 15c
August 6, 2026 8:02 AM - StreetInsider
Form 10-Q Foghorn Therapeutics For: Jun 30
August 6, 2026 7:03 AM - SEC Filing
Form 8-K Foghorn Therapeutics For: Aug 06
August 6, 2026 7:02 AM - SEC Filing
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
August 6, 2026 7:01 AM - StreetInsider
Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director
July 1, 2026 7:00 AM - StreetInsider
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Lynch Thomas J. Jr.
June 25, 2026 4:07 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Duty Stuart
June 25, 2026 4:06 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Biller Scott
June 25, 2026 4:05 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Gallagher Neil
June 25, 2026 4:04 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Mendelsohn Michael
June 25, 2026 4:04 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: SMITH IAN F
June 25, 2026 4:03 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: GILL SIMBA
June 25, 2026 4:02 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: PARSHALL B LYNNE
June 25, 2026 4:01 PM - SEC Filing
Form 4 Foghorn Therapeutics For: Jun 24 Filed by: Cole Douglas G.
June 25, 2026 4:01 PM - SEC Filing
Form 8-K Foghorn Therapeutics For: Jun 24
June 24, 2026 4:01 PM - SEC Filing
Next-Generation DNA Repair Therapies Open New Frontiers in Oncology
June 22, 2026 8:30 AM - StreetInsider
Nuvation Bio (NUVB) Reiterated at Market Outperform by Citizens Amid Acquisition by GSK
June 10, 2026 5:19 AM - StreetInsider
Full Article List
